Poly Medicure Limited

Healthcare · Healthcare Equipment & Supplies

NSE: POLYMED BSE: 531768

₹1673.80

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Healthcare Equipment & Supplies

The largest companies in the same industry by market cap. This company ranks #1 of 13. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Poly Medicure Limited (this stock)	16,966	50.5	10.2%	-14.2%	—	75	6	31
Fischer Medical Ventures Limited	2,196	—	0.6%	-68.9%	—	36	0	47
Tarsons Products Limited	1,704	86.1	2.3%	3.7%	—	33	33	66
Laxmi Dental Limited	1,052	59.4	11.8%	-41.6%	—	60	17	13
Fabtech Technologies Limited	645	14.5	—	—	0.41%	71	86	15
Prevest Denpro Limited	456	—	—	-33.0%	—	67	—	65
Nureca Limited	350	172.1	0.5%	58.9%	—	40	60	88
CHOKSI ASIA LIMITED	111	21.5	8.7%	117.3%	—	56	74	30

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹17,208 Cr

EV / EBITDA

30.4x

EV / Sales

10.07x

Market cap / Sales

9.92x

Earnings yield

1.98%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 460 Cr, up 8.1% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 88 Cr, up 0.2% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	431	119	88	₹8.6900
March 31, 2026	443	107	81	₹7.9500
Dec. 31, 2025	419	106	78	₹7.7300
Sept. 30, 2025	417	118	89	₹8.7900
June 30, 2025	384	117	88	₹8.6800
March 31, 2025	421	116	87	₹
Dec. 31, 2024	411	113	85	₹8.4800
Sept. 30, 2024	402	117	87	₹8.9900
June 30, 2024	367	96	72	₹7.5300
March 31, 2024	361	94	71	₹7.3500
Dec. 31, 2023	321	82	61	₹6.4100
Sept. 30, 2023	320	78	59	₹6.1700
June 30, 2023	306	81	61	₹6.3100

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	460	458	448	450	425	433	430	384	377	337	333	319	302
Operating revenue	431	443	419	417	384	411	402	367	361	321	320	306	293
Other income	29	15	30	34	41	22	27	17	16	17	13	13	9
Operating expenses	310	322	307	305	282	295	290	266	264	236	237	220	212
Operating profit	121	121	112	111	102	116	113	101	97	84	83	85	82
Operating profit margin	28.0%	27.3%	26.8%	26.7%	26.5%	28.1%	28.1%	27.5%	27.0%	26.3%	25.8%	27.9%	27.8%
Depreciation	26	26	25	24	23	21	20	19	16	16	15	15	15
Interest	4	4	4	3	3	3	3	3	3	3	2	2	2
Exceptional items, gain / (loss)	—	—	-7	—	—	—	—	—	—	—	—	—	—
Profit before tax	119	107	106	118	117	113	117	96	94	82	78	81	73
Tax	31	26	28	29	29	28	30	24	23	21	19	20	16
Net profit	88	—	78	—	88	85	87	72	71	61	59	61	57
EPS	8.69	7.95	7.73	8.79	8.68	8.48	8.99	7.53	7.35	6.41	6.17	6.31	6.00
Net profit (TTM)	—	—	—	—	333	315	292	264	252	239	225	211	179
EPS (TTM)	33.16	33.15	33.68	34.94	33.68	32.35	30.28	27.46	26.24	24.89	23.43	21.98	18.67

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	1,662	448	336
March 31, 2025	1,602	443	331

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	17.3%	18.4%	1,782^†	—	1,365^†	1,104^†	918^†	767^†	665^†	603^†	524^†	454^†
Operating revenue	15.9%	17.3%	1,662	1,602	1,307^†	1,068^†	879^†	747^†	646^†	587^†	510^†	443^†
Other income	—	—	119^†	—	58^†	36^†	39^†	19^†	19^†	16^†	14^†	11^†
Operating expenses	—	—	1,216^†	—	958^†	804^†	666^†	535^†	486^†	453^†	—	—
Operating profit	19.0%	16.0%	446^†	—	350^†	264^†	214^†	212^†	160^†	134^†	—	—
Operating profit margin	—	—	26.8%^†	—	26.7%^†	24.8%^†	24.3%^†	28.4%^†	24.8%^†	22.9%^†	—	—
Depreciation	—	—	98^†	—	62^†	56^†	53^†	46^†	39^†	36^†	—	—
Interest	—	—	13^†	—	11^†	8^†	5^†	12^†	18^†	13^†	9^†	7^†
Exceptional items, gain / (loss)	—	—	-7^†	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	23.7%	20.9%	448	443	335^†	237^†	195^†	173^†	122^†	101^†	96^†	73^†
Tax	—	—	112^†	—	83^†	58^†	49^†	44^†	29^†	34^†	26^†	—
Net profit	23.3%	21.0%	336	331	252^†	179^†	146^†	130^†	92^†	66^†	70^†	53^†
EPS	21.1%	17.9%	33.15^†	—	26.24^†	18.67^†	15.23^†	14.54^†	10.47^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	26.8%^†	—	26.7%^†	24.8%^†	24.3%^†	28.4%^†	24.8%^†	22.9%^†	—	—
EBIT margin	27.7%^†	—	26.4%^†	23.0%^†	22.7%^†	24.8%^†	21.6%^†	19.4%^†	20.8%^†	18.1%^†
PBT margin	26.9%	27.6%	25.6%^†	22.2%^†	22.1%^†	23.2%^†	18.8%^†	17.1%^†	18.9%^†	16.5%^†
Net margin	20.2%	20.7%	19.3%^†	16.8%^†	16.6%^†	17.3%^†	14.3%^†	11.3%^†	13.8%^†	12.0%^†
Interest coverage	34.34x^†	—	32.18x^†	29.53x^†	39.13x^†	15.62x^†	7.90x^†	8.72x^†	11.15x^†	11.47x^†
Dividend payout	—	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—	—
Current ratio	3.91x	5.44x	—	—	—	—	—	—	—	—
Quick ratio	3.24x	4.71x	—	—	—	—	—	—	—	—
Debt to equity	0.08x	0.06x	—	—	—	—	—	—	—	—
Return on equity	11.0%	12.1%	—	—	—	—	—	—	—	—
Return on assets	9.5%	10.6%	—	—	—	—	—	—	—	—
Return on capital employed	14.7%^†	—	—	—	—	—	—	—	—	—
Asset turnover	0.47x	0.51x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	245	-268	28	296	-50
March 31, 2025	237	-1,191	953	325	-88

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	3,550	3,053	3,002	246	3	1,640	419	6	1,200	281
March 31, 2025	3,140	2,744	2,694	170	0	1,860	342	1	1,030	250

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.